| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.05B | +7.7% |
| R&D Expense | $155.4M | +15.4% |
| SG&A Expense | $141.4M | +24.8% |
| Operating Income | $124.7M | -16.3% |
| Pre-tax Income | $115.6M | -17.1% |
| Income Tax | $42.4M | +131.6% |
| Net Income | $73.2M | -39.6% |
| EPS (Basic) | $0.20 | -41.2% |
| EPS (Diluted) | $0.19 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $415.5M | -16.5% |
| Accounts Receivable | $10.4M | -12.8% |
| Current Assets | $8.11B | +14.2% |
| Total Assets | $8.96B | +12.9% |
| Current Liabilities | $8.08B | +13.4% |
| Total Liabilities | $8.25B | +14.5% |
| Stockholders' Equity | $704.4M | -2.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $233.5M | +32.0% |
| Capital Expenditures | $26.9M | +228.2% |
| Investing Cash Flow | -$218.3M | +88.9% |
| Financing Cash Flow | $738.0M | +72.5% |
| Free Cash Flow | $206.6M | +22.4% |
| -38.7% |